Navigation Links
New sensors developed to predict effectiveness of radiotherapy treatment

The human population is exposed to both natural and artificial sources of radiation, which can cause cancer and other defects. Strangely, the same radiation that causes such effects is used for the treatment of cancer, //referred to as radiotherapy. It is however very difficult to assess if the precise dose of radiation is being delivered.

New sensor systems have now been developed that can assess the effectives of the radiation treatment to improve the accuracy and reliability. The system called as Intensity Modulated Radiotherapy (IMRT) has been developed for real-time radiation monitoring.

The setup sends the external beam radiation from different angles to different regions of the tumor. A collimator modulates and shapes the beams so that the tumour receives a uniform dose. It improves clinical outcomes by more accurately targeting tumors and minimizing the amount of radiation absorbed by healthy tissue.

INVORAD developed two sensors that can perform the task in a simple way. The small size of the sensor, the response to different forms of radiation used in radiotherapy and compatibility of the device with microprocessors offer a superior advantage. The device is based on the working principle of semiconductor material that senses the incoming radiation and transmits it to a display unit.

INVORAD also developed a cylindrical 'body phantom'. The 'phantom' is given the prescribed dose and the sensors pick up the dose actually delivered. If the 'phantom' treatment matches the prescription of the simulator, the patient is given treatment. If not, the treatment plan needs to be corrected.

The two devices are being tested in patients undergoing radiotherapy treatment. If successful, there would soon be commercialization of the sensor system. This is hoped to reduce the side effects patients associated with radiotherapy by improving accuracy of dose delivery, which has a significant impact in cancer tr eatment.
'"/>




Related medicine news :

1. New ways developed to understand dyslexia
2. Researchers developed world’s smallest toothbrus
3. Blood test developed for malignant hyperthermia
4. New ultralight hand with better functionality and flexibility developed
5. Novel antibiotic dressing developed for improved wound healing
6. New spinal surgery technique developed by UCSF Surgeon
7. Child specific HIV drugs and laboratory tests should be developed
8. Vaccines developed, to treat melanoma in dogs
9. Bionic muscles developed by scientists powered by alcohol and hydrogen
10. Vaccine for ear and sinus infections to be developed…
11. Canadians wait an eternity - Issues of a developed healthcare system.
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/26/2016)... Clarkston, Michigan (PRWEB) , ... June 26, 2016 ... ... respect to fertility once they have been diagnosed with endometriosis. These women need ... but they also require a comprehensive approach that can help for preservation of ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... First ... United States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell ... facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive ...
(Date:6/24/2016)... , ... June 24, 2016 , ... A recent ... most people are unfamiliar with. The article goes on to state that individuals are ... many of these less common operations such as calf and cheek reduction. The Los ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg ... Legal Elite. The attorneys chosen by their peers for this recognition are considered among ... Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite Hall ...
(Date:6/24/2016)... Norcross, Georgia (PRWEB) , ... June 24, 2016 ... ... Year” awards today at the Clinical Decision Making in Emergency Medicine conference in ... who have authored journal articles published in Emergency Medicine Practice and ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... , June 26, 2016 One of ... has announced the formation of a new biotechnology company, Noxopharm Limited ... $6m in an IPO and to list on the ASX. ... candidate, NOX66, ready to enter a Phase 1 clinical study later ... designed to address one of the biggest problems facing cancer patients ...
(Date:6/26/2016)... , June 27, 2016 Jazz Pharmaceuticals ... waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of ... acquisition of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: ... p.m. (Eastern Daylight Time). As previously announced ... into a definitive merger agreement under which Jazz Pharmaceuticals ...
(Date:6/26/2016)... 2016  VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) ... measures required to build a strong and stable market ... listed on the OTC Markets-pink current trading platform. ... "We are seeing an anomaly in market trading activities ... by the Company, but shareholders and market players as ...
Breaking Medicine Technology: